Veradermics 

$63.82
0
-$0.37-0.58% Monday 20:00

Statistics

Day High
65.29
Day Low
61.55
52W High
69.41
52W Low
32
Volume
110,772
Avg. Volume
470,617
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

3JunExpected
Q4 2025
Next
-1.81
-1.43
-1.04
-0.65
Expected EPS
-0.654387
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2023
2024
2025
0Revenue
-48.15MNet Income

Analyst Ratings

$78.33Average Price Target
The highest estimate is 85.00.
From 4 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow MANE. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Veradermics, Incorporated operates as a biopharmaceutical company focused on developing novel therapeutics for dermatologic and aesthetic conditions. The company develops treatments for Pattern Hair Loss affecting adults and children. The company's products include VDPHL01, an oral, non-hormonal treatment for men and women with PHL for chronic hair loss therapy. Additionally, it engages in the development of VDMN, a dissolvable microarray patch technology for immunotherapy of common warts; VDAA for the treatment of alopecia areata; and VDMC for the treatment of molluscum contagiosum. Its products are used for the treatment of androgenetic alopecia, common warts, molluscum contagiosum, alopecia areata, and atopic dermatitis. The company serves healthcare providers and clinicians treating dermatologic and aesthetic conditions in both adult and pediatric populations, as well as the broader medical and clinical research community involved in dermatology. Veradermics, Incorporated was founded in 2019 and is based in New Haven, Connecticut.
Show more...
CEO
Dr. Reid Waldman M.D.
Country
US
ISIN
US9229671048

Listings

0 Comments

Share your thoughts

FAQ

What is Veradermics stock price today?
The current price of MANE is $63.82 USD — it has decreased by -0.58% in the past 24 hours. Watch Veradermics stock price performance more closely on the chart.
What is Veradermics stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Veradermics stocks are traded under the ticker MANE.
When is the next Veradermics earnings date?
Veradermics is going to release the next earnings report on June 03, 2026.
What were Veradermics earnings last quarter?
MANE earnings for the last quarter are -1.06 USD per share, whereas the estimation was -1.81 USD resulting in a +41.47% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Veradermics revenue for the last year?
Veradermics revenue for the last year amounts to 0 USD.
What is Veradermics net income for the last year?
MANE net income for the last year is -48.15M USD.
When did Veradermics complete a stock split?
Veradermics has not had any recent stock splits.
Where is Veradermics headquartered?
Veradermics is headquartered in New Haven, US.